A potential autocrine loop between heregulin-alpha and erbB-3 receptor in human prostatic adenocarcinoma

British Journal of Urology

Volumn 79, Issue 2, 1997, Pages 212-216

  Leung, H Y ^a  

^a Department of Surgery ^*  (United Kingdom)

Author keywords

Autocrine loop; erbB 3; Heregulin alpha; Outcome; Prostate cancer

Indexed keywords

ANDROGEN; ANTIBODY; EPIDERMAL GROWTH FACTOR; EPIDERMAL GROWTH FACTOR RECEPTOR; HORMONE; NEU DIFFERENTIATION FACTOR; ONCOPROTEIN;

ADULT; AGED; ARTICLE; AUTOCRINE EFFECT; BONE METASTASIS; BONE SCINTISCANNING; CANCER GRADING; CLINICAL ARTICLE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; PROSTATE HYPERTROPHY; TRANSURETHRAL RESECTION;

EID: 0031401067     PISSN: 00071331     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1464-410X.1997.30412.x     Document Type: Article

References (25)

1. Dearnley DP. Cancer of the prostate. Br Med J 1944; 308: 780-4
2. Connolly JM, Rose DP. Production of epidermal growth factor and transforming growth factor-alpha by the androgen-responsive LNCaP human prostate cancer cell line. Prostate 1990; 16: 209-18
3. McKeehan WL, Adams PS, Rossner MP. Direct mitogenic effects of insulin, epidermal growth factor, glucocorlicoid. choleratoxin, unknown pituitary factors and possibly prolactin, but not androgen, on normal rat prostate epithelial cells in serum-free, primary cell culture. Cancer Res 1984; 44: 4998-201
4. Schuurmans ALG, Bolt J, Mulder E. Androgens and transforming growth factor modulate the growth response to epidermal growth factor in human proslatic tumour cells. Mol Cell Endocrinol 1988; 60: 101-4
5. Wildings GE, Valverius C, Knabbe C et al. Role of transforming growth factor-alpha in human prostate cancer cell growth. Prostate 1989: 15: 1-12
6. Harper MF, Goddard L, Glynne-Jones et al. An immunocyto-chemical analysis of TGF-alpha expression in benign and malignant prostate tumors. Prostate 1993; 23: 9-23
7. Ibrahim GK, Kerns BM, MacDonald JA et al. Differential immunoreactivity of epidermal growth factor receptor in benign, dysplastic and malignant prostatic tissues. J Urol 1993; 67: 152-5
8. Morris GL, Dodd JG. Epidermal growth factor receptor mRNA levels in human prostatic tumors and cell lines. J Urol 1990; 143: 1272-4
9. Davies P, Eaton C, France C et al Growth factor receptors and oncogene expression in prostate cells. Am J Clin Oncol 1988; 11: 1-6
10. McCann A, Dervan PA, Gullick WJ et al. c-erbB-2 oncoprotein expression in malignant and non-malignant tissues. Proc Am Assoc Cancer Res 1989; 30: 914
11. Ware JL, Maygarden SJ, Kootnx WW et al. Differential reactivity with anti-erb-B2 antiserum among human malignant and benign prostatic tissue. Proc Am Assoc Cancer Res 1989; 30: 1373
12. Kuhn EJ, Kurnot RA, Sesterhann IA et al. Expression of the c-erb-B2 HER-2/neu; oncoprotein in human prostatic carcinoma. J Urol 1993; 150: 1427-33
13. Holmes WE. Sliwkowski MX, Akita RW et al. Identification of heregulin, a specific activator of p185ERBB2. Science 1992; 256: 1205-10
14. Morrissey TK, Levi ADO, Nuijens A et al. Axon-induced mitogenesis of human schwann-cells involves heregulin. Proc Natl Acad Sci USA 1995; 92: 1431-5
15. Marte BM, Jeschke M, Grausporta D et al. Neu differentiation factor heregulin modulates growth and diffentiation of HC11 mammary epithelial cells. Mol Endocrinol 1995; 9: 14-23
16. Culouscou JM, Carlton GW, Aruffo A. HER4 receptor activation and phosphorylation of SHC proteins by recombinant heregulin-FC fusion proteins. J Biol Chem 1995; 270: 12857-63
17. Kita YA, Barff J, Luo Y et al. NDF/heregulin stimulates the phosphorylation of HER3/ERBB3. FEBS Letters 1994; 349: 139-43
18. Carraway KL, Sliwkowski MX, Akita R et al. The ERBB3 gene product is a receptor for heregulin. J Biol Chem 1994; 269: 14303-6
19. Lemoine NR, Lobresco M, Leung H et al. The erbB-3 gene in human pancreatic cancer. J Path 1992; 168: 269-73
20. Gullick WJ. Production of antisera to synthetic peptides. In Walker J ed. Methods in Molecular Biology. New Jersey: Humana Press Inc, 199?: 341-54
21. Rajkumar T, Majhi U, Malligarjuna V, Gullick WJ. Prevalence of c-erbB3 expression in squamous cell carcinoma of the cervix as determined by the monoclonal antibody RTJ-2. Int J Oncol 1995; 6: 105-9
22. Sliwkowski MX, Schaefer G, Akita RW et al. Coexpression of ERBB2 and ERBB3 proteins reconstitutes a high-affinity receptor for heregulin. J Biol Chem 1994; 269: 14661-5
23. Bacus SS, Gudkkov AV, Zelnic CR et al. Neu differentiation factor heregulin; induces expression of intercellular adhesion molecules. 1: implications for mammary tumours. Cancer Res 1993; 53; 5251-61
24. Normanno N, Kim N, Wen D et al. Expression of messenger RNA for phiregulin, heregulin, and cripto-1, three new members of the epidermal growth factor family, in human breast carcinomas. Breast Cancer Res and Treat 1995; 35: 293-7
25. Rajkumar T, Gullick WJ. A monoclonal antibody to the human c-erbB3 protein stimulates the anchorage independent growth of breast cancer cell lines. Br J Cancer 1994; 70: 459-65